|
W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (C3); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
| Catalog Number |
RMT281416 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Aneurysm (1708)
|
| Date of Event |
05/30/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Concomitant medical products: patient medications: atenolol, atorvastatin calcium, lisinopril, multiple vitamins, aspirin.According to the gore® excluder® aaa endoprosthesis instructions for use, adverse events which may occur and require intervention include endoleak.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2011, the patient was implanted with gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.It was reported that during a routine follow up visit, computed tomography images dated (b)(6) 2019, revealed the aneurysm sac has increased in size measuring 7.9 x 7.5 cm.On (b)(6) 2019, the physician reintervened and pre-op images and revealed a proximal type i endoleak and implanted a gore® excluder® aortic extender endoprosthesis.The endoleak was resolved and the patient tolerated the reintervention.
|
| |
|
Search Alerts/Recalls
|
|
|